Evonik Industries (EVK) Given a €38.00 Price Target at Baader Bank
Evonik Industries (FRA:EVK) has been given a €38.00 ($45.24) price target by investment analysts at Baader Bank in a research report issued on Thursday. The brokerage presently has a “buy” rating on the stock. Baader Bank’s price target suggests a potential upside of 21.41% from the stock’s current price.
A number of other brokerages have also commented on EVK. Deutsche Bank set a €34.00 ($40.48) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a report on Tuesday, November 7th. Berenberg Bank set a €37.00 ($44.05) price objective on shares of Evonik Industries and gave the company a “buy” rating in a report on Tuesday, November 7th. Goldman Sachs Group set a €29.00 ($34.52) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a report on Monday, November 6th. Commerzbank set a €39.00 ($46.43) price objective on shares of Evonik Industries and gave the company a “buy” rating in a report on Thursday, November 9th. Finally, Independent Research set a €33.00 ($39.29) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a report on Monday, November 6th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of €33.75 ($40.18).
Shares of Evonik Industries (FRA EVK) traded down €0.25 ($0.30) during trading hours on Thursday, reaching €31.30 ($37.26). 765,304 shares of the company were exchanged. Evonik Industries has a 1 year low of €26.78 ($31.88) and a 1 year high of €32.97 ($39.25).
WARNING: This report was reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/12/14/evonik-industries-evk-given-a-38-00-price-target-at-baader-bank.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.